Met Life Investment Management, LLC Instil Bio, Inc. Transaction History

Met Life Investment Management, LLC

$17.1 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 May 10, 2024	BUY	$4.65 - $7.37 $53,972 - $85,543	11,607 Added 36.58%	43,334 $209,000
Q3 2022 Jun 14, 2023	BUY	$4.65 - $7.37 $201,503 - $319,371	43,334 New	43,334 $209,000
Q3 2022 Mar 22, 2023	BUY	$4.65 - $7.37 $53,972 - $85,543	11,607 Added 36.58%	43,334 $209,000
Q3 2022 Nov 14, 2022	BUY	$4.65 - $7.37 $53,972 - $85,543	11,607 Added 36.58%	43,334 $210,000
Q2 2022 Jun 20, 2023	BUY	$4.21 - $11.15 $133,570 - $353,756	31,727 New	31,727 $146,000
Q1 2022 May 10, 2024	BUY	$8.48 - $18.1 $269,044 - $574,258	31,727 New	31,727 $341,000
Q1 2022 Jun 20, 2023	BUY	$8.48 - $18.1 $269,044 - $574,258	31,727 New	31,727 $341,000
Q1 2022 Mar 22, 2023	BUY	$8.48 - $18.1 $95,934 - $204,765	11,313 Added 55.42%	31,727 $341,000
Q1 2022 May 12, 2022	BUY	$8.48 - $18.1 $95,934 - $204,765	11,313 Added 55.42%	31,727 $341,000
Q4 2021 May 17, 2024	BUY	$15.37 - $22.5 $184,808 - $270,540	12,024 Added 143.31%	20,414 $349,000
Q4 2021 Jun 21, 2023	BUY	$15.37 - $22.5 $313,763 - $459,315	20,414 New	20,414 $349,000
Q4 2021 Mar 22, 2023	BUY	$15.37 - $22.5 $184,808 - $270,540	12,024 Added 143.31%	20,414 $349,000
Q4 2021 Feb 15, 2022	BUY	$15.37 - $22.5 $184,808 - $270,540	12,024 Added 143.31%	20,414 $349,000
Q3 2021 Jun 21, 2023	BUY	$15.05 - $23.28 $126,269 - $195,319	8,390 New	8,390 $150,000
Q2 2021 May 17, 2024	BUY	$15.31 - $24.63 $128,450 - $206,645	8,390 New	8,390 $162,000
Q2 2021 Jun 21, 2023	BUY	$15.31 - $24.63 $128,450 - $206,645	8,390 New	8,390 $162,000
Q2 2021 Mar 22, 2023	BUY	$15.31 - $24.63 $128,450 - $206,645	8,390 New	8,390 $162,000
Q2 2021 Aug 16, 2021	BUY	$15.31 - $24.63 $128,450 - $206,645	8,390 New	8,390 $162,000

Others Institutions Holding TIL

# of Institutions

Shares Held

1.9M

Call Options Held

Put Options Held

View Full List

About Instil Bio, Inc.

Ticker TIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,694,000
Market Cap $2.67B
Description
Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small ce...

More about TIL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account